✦ LIBER ✦

Therapeutic options for acute myelogenous leukemia

✍ Scribed by Elihu H. Estey

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 157 KB
Volume: 92
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20010901)92:5<1059::aid-cncr1421>3.0.co;2-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early deaths in acute myelogenous leukem

Early deaths in acute myelogenous leukemia

✍ Dr. I. E. Smith; R. Powles; H. MacD. Clink; B. Jameson; H. E. M. Kay; T. J. McEl 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 451 KB 👁 2 views

Lymphosarcoma terminating in acute myelo

Lymphosarcoma terminating in acute myelogenous leukemia

✍ Raymond B. Weiss; Richard D. Brunning; B. J. Kennedy 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB 👁 2 views

Immunotherapy for acute myelogenous leuk

Immunotherapy for acute myelogenous leukemia using irradiated and unirradiated leukemia cells

✍ Dr. Ray Powles 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 1 views

Personalized medicine for acute myelogen

Personalized medicine for acute myelogenous leukemia—At the entrance gate

✍ Ronan T. Swords; Bruce J. Dezube; Bruno C. Medeiros 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 1 views

Increased cerebral blood flow after leuk

Increased cerebral blood flow after leukapheresis for acute myelogenous leukemia

✍ Margaret T. Kasner; Adrienne Laury; Scott E. Kasner; Martin Carroll; Selina M. L 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

Therapeutic choices in younger patients

Therapeutic choices in younger patients with chronic myelogenous leukemia

✍ Hagop M. Kantarjian; Francis J. Giles; Susan O'Brien; Sergio Giralt; Moshe Talpa 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 1 views

## Background: Allogeneic stem cell transplantation (sct) and interferon (ifn)-alpha therapy have significantly improved the prognosis of patients with philadelphia (ph) chromosome positive chronic myelogenous leukemia (cml). both therapies may be suitable for younger patients. the authors reviewed